Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2041–2064 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Alcohol-Associated Hepatitis
Interventions: bacteriophage preparation; Drug
Lead sponsor: Nterica Bio inc; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Coronado, California

Conditions: Stroke, Dysarthria, Apraxia, Dysphagia, Hemiparesis After Stroke
Interventions: Boston Scientific Vercise Deep Brain Stimulation (DBS) System, Rehabilitation Training Protocol; Device · Other
Lead sponsor: Pirondini, Elvira, PhD; Other
Eligibility: 22 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Frostbite
Interventions: Standard of care plus Epoprostenol infusion for 8 hours (hrs) per day up to 5 days maximum, Standard of Care + Placebo (Normal Saline)infusion for 8 hours per day up to 5 days maximum; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Trauma Blunt, Orthopedic
Interventions: Comprehensive trauma recovery programming (C-TRP), Standard of Care (Investigator Selected); Behavioral · Other
Lead sponsor: Stephanie Di Stasi; Other
Eligibility: 18 Years and older
Enrollment: 804 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 7
States / cities: Aurora, Colorado • Baltimore, Maryland • Minneapolis, Minnesota + 3 more

Conditions: Hepatocellular Carcinoma (HCC)
Interventions: Zanzalintinib, Tegavivint; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Pain, Musculoskeletal Pain
Interventions: Coaching; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2029 – 2031
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Thromboembolic Stroke
Interventions: NaF PET-CT; Drug
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Summit, New Jersey

Conditions: Recurrent High-Grade Gliomas, Brain Neoplasm, Glioma
Interventions: SRN-101, Blood Specimen Collection, Surgical Resection, Magnetic Resonance Imaging (MRI); Drug · Procedure
Lead sponsor: Nicholas Butowski; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Breast Cancer Survivor, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Interventions: integrated medication monitoring (MM) system; Device
Lead sponsor: San Diego State University; Other
Eligibility: 21 Years to 70 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: San Diego, California

Conditions: Substance Use (Drugs, Alcohol), Tobacco Use, Adolescent Substance Use
Interventions: Integrated Community Engagement Collaborative, School-Based Data Collection and Reporting without Network Coordinator Support; Other
Lead sponsor: West Virginia University; Other
Eligibility: 10 Years and older
Enrollment: 25,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: C-Reactive Protein
Interventions: LY5625573, Midazolam, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Los Alamitos, California • Dallas, Texas

Conditions: Human Papillomavirus (HPV) Vaccines
Interventions: Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1,296 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Idiopathic Inflammatory Myopathies
Interventions: Placebo, Nerandomilast; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 23
States / cities: Scottsdale, Arizona • Irvine, California • Los Angeles, California + 19 more

Conditions: Patient Engagement
Interventions: WI-CARE Protocol; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Epstein Barr Virus (EBV) Infection
Interventions: MVA-BN-EBV, Placebo; Biological
Lead sponsor: Bavarian Nordic; Industry
Eligibility: 18 Years to 30 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: GLP - 1, Obesity & Overweight, Muscle Loss, Exercise Intervention, Dietary Assessment
Interventions: Semaglutide, Dietary Counseling, Exercise; Drug · Behavioral
Lead sponsor: William Marsh Rice University; Other
Eligibility: 40 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Transitioning Voice of Transgender and Gender Diverse People
Interventions: Attuned: A mobile application, In-Person Voice Modification Therapy; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 2
States / cities: Ithaca, New York • New York, New York

Conditions: Osteoarthritis, Tendinitis, Sports Injury, Degenerative Disc Disease, Degenerative Arthritis, Ligament Injury, Neuropathy, Pelvic Pain
Interventions: Umbilical Allograft; Other
Lead sponsor: R3 Stem Cell; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: Encino, California

Conditions: Total Knee Arthroplasty
Interventions: Intraosseous Vamcomycin Administration; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: San Diego, California

Conditions: Glioblastoma
Interventions: Gallium Maltolate, Surgical Intervention; Drug · Procedure
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: PPA
Interventions: Active tES, Cognitive Interventions; Device · Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 45 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Congenital Adrenal Hyperplasia
Interventions: exposure to healthcare transition protocol; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 16 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Cognition, BDNF
Interventions: d-beta-hydroxybutrate, Placebo; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 35 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Abscess
Interventions: Standard of care breast abscess drainage, Methylene Blue, Lipid Emulsion, Insertion of optical fiber, Laser illumination, Photodynamic therapy; Procedure · Drug · Device
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Rochester, New York

Search by objective public record fields.

Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis

Deep Brain Stimulation + Therapy for Stroke

Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO)

The Healing and Empowerment Actions for Recovery From Trauma (HEART) Trial

Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma

Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care

A Novel Method for Determination of Thromboembolic Stroke Origin

A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.

Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication

The ICEC Cluster Trial: Integrated Community Engagement Collaborative for Youth Substance Use Prevention in Rural America

A Study of Single and Multiple Doses of LY5625573 in Healthy Participants, Including Japanese and Chinese Populations, and Participants With Inflammation (High C-Reactive Protein)

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

Developing and Testing a Method for Engagement in Research Using WhatsApp

Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults

Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1

Novel Delivery Method of Transgender Voice Modification Training Using a Mobile Application

Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

IO Vancomycin Administration in TKA

Oral Gallium Maltolate for Recurrent Glioblastoma

Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive Aphasia

Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia

Investigating the Evolutionary Impact of Metabolic Flexibility on Physical Activity-Dependent BDNF and Cognition: Insights From the Val66Met Polymorphism

A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses